According to the latest study on ‘Radiofrequency Ablation Devices Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Product and Application.’ The global radiofrequency ablation devices market was valued at US$ 3,302.55 million in 2019 and is projected to reach US$ 7,711.72 million in 2027; it is expected to grow at a CAGR of 11.5% during 2020–2027. The report provides trends prevailing in the global radiofrequency ablation devices market and the factors driving market along with those that act as hindrances.

 

The players in the radiofrequency ablation devices market are coming up with multiple and advanced products for radiofrequency ablation procedure. For instance, in February 2019, Medtronic received FDA clearance for its Accurian radiofrequency system launched it in the US for nerve tissue ablation. This system is used to conduct a minimally invasive procedure in which radio waves heat up a small area of nerve tissue to stop it from sending pain signals, thereby reducing pain. With this launch, the company has expanded its pain management product portfolio. Medtronic is at the forefront of medical device innovation and develops high-quality pain therapies to reduce pain and improve quality of life. In November 2019, Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, launched the Sonata 2 System in the US and Europe; it is the world’s first and only transcervical fibroid ablation system. Further, in July 2017, Stryker received FDA approval for MultiGen 2 Radiofrequency Generator. MultiGen 2 RF Generator, help surgeons to gain  control and efficiency, which uplifts the reliability of radiofrequency ablation procedures. Thus, such innovations are expected to be a prevalent trend in the radiofrequency ablation devices market in the coming years.

 

Based on product, the global radiofrequency ablation devices market is segmented into devices and disposables. The disposables segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period. Based on application, the radiofrequency ablation devices market has been segmented into surgical oncology, cardiology, gynecology, cosmetology, and pain management. The surgical oncology segment held the largest share of the global radiofrequency ablation devices market in 2019, and is expected to continue its dominance during the forecast period. Owing to rising prevalence of cancer, development of advanced technologies to treat cancer and increasing number of health club visits is likely to drive the surgical oncology segment.

 

Avanos Medical, Inc., Stryker, Abbott, Medtronic, Boston Scientific, Bard (BD), Angiodynamic, Hologic, Articure, and Merit medical are among the leading companies operating in the radiofrequency ablation devices market.  

 

The Report Segments Global Radiofrequency Ablation Devices Market as Follows:

 

By Product

·        Devices

·        Disposables

By Application

·        Surgical Oncology

·        Cardiology

·        Cosmetology

·        Gynecology

·        Pain Management

By Geography

·        North America

§  US

§  Canada

§  Mexico

·        Europe

§  France

§  Germany

§  UK

§  Spain

§  Italy

·        Asia Pacific (APAC)

§  China

§  India

§  Japan

§  Australia

§  South Korea

·        Middle East and Africa (MEA)

§  Saudi Arabia

§  UAE

§  South Africa

·        South & Central America (SCAM)

§  Brazil

§  Argentina

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: [email protected]

Phone: +1-646-491-9876